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Schange of left ventricular ejection fraction (LVEF) (DcTnI : p¼0.0874, DCKMB:
p¼0.9195) after TA-TAVR was similar between tertiles of both cardiac biomarkers.
Conclusions: In pts undergoing TA-TAVR in the PARTNER trial, a greater degree of
cTnI or CKMB elevation was not associated with signiﬁcantly higher all-cause or
cardiovascular mortality rates, at 30-days and at 1 year. Moreover, the degree of
myocardial injury had no impact on improvement in NYHA functional class or on
LVEF recovery.Invasive Hemodynamic and Clinical Variables Stratiﬁed by Valvuloarterial
Impedance Index Ratio
ZvaPost/ZvaPre <0.85
(n=38)
ZvaPost/ZvaPre>0.85
(n=47) p value
Zva-Post/Zva-Pre,
mean +SD
0.72 +0.1 1.1 +0.1 p<0.01
Aortic valve area, cm2 ,
mean, +SD
0.61 +0.2 0.67 +0.2 p¼0.78
Mean transvalvular
pressure gradient,
mmHg, mean, +SD
46.9 +17.2 42.7 +12.8 p¼0.84
Stroke volume index
,mmHg/mL/m2, mean
+SD
31.5 +9.5 32.5 +10.9 p¼0.94
Systolic arterial
pressure, mmHg, mean
+SD
131.1 +25.4 126 +28 p¼0.89
STS mortality risk %,
mean +SD
10.4 +6.1 10.7 +7.2 p¼0.97
LVEF%, mean +SD 41.7 +16.4 41.2 +17.8 p¼0.98
Zva: valvuloarterial impedance; ZvaPost/ZvaPre: valvuloarterial impedance index ratio; STS:
Society of Thoracic Surgeons; LVEF: left ventricular ejection fractionTCT-755
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Background: It is controversial whether female sex affects mortality after trans-
catheter aortic valve implantation (TAVI). Post-procedural AR  2 is a predictor of
mortality after (TAVI). Sex-differences in aortic and anatomic factors may affect post-
procedural AR. The aim of this study was a) to assess sex-differences in mortality after
TAVI, b) to investigate sex-differences in post-procedural AR and the interaction
between female sex and AR on mortality after TAVI.
Methods: This is a multicenter registry enrolling consecutive patients with symp-
tomatic severe aortic stenosis undergoing TAVI with the CoreValve system (92.8%)
or the Edwards SAPIEN valve system (7.2%). Multivariable Cox regression was
performed to compute hazard ratios (HR) with 95% conﬁdence interval (CI).
Results: A total of 656 patients, median age 83 yrs, (25th-75th percentile 79-86 yrs),
women (53.1%), men (46.9%) were enrolled. Body surface area (1.71 vs 1.81,
p<0.001) and annulus diameter (21.5 mm vs 23 mm, p<0.001) were signiﬁcantly
smaller in women than in men. Procedural success was similar in women as compared
to men (97.9% vs 96.7% in men, p¼0.32). Post-procedural AR  2 was signiﬁcantly
less frequent in women than in men (20.9% vs 29.6%, p¼0.01). After a median
follow-up of 372 days, all-cause mortality tended to be lower in women than in men
(20.7% vs 26.6%, logrank p¼0.10), while it was signiﬁcantly higher in patients with
AR  2 than in those without (34.8% vs 19.7%, logrank P<0.001). At multivariable
Cox regression post-procedural AR  2 (HR1.73, 95% conﬁdence interval (CI)
1.22-2.43, p¼0.002), but not female sex (p¼0.17) was an independent predictor of all-
cause death. AR  2 was a signiﬁcant predictor of all-cause death among men (HR
2.96, p<0.001), but not among women (HR 0.86, p¼0.60; p for interaction 0.002).
Conclusions: Postprocedural AR  2, but not female sex, is an independent predictor
of all-cause mortality at mid-term follow-up. AR  2 occurs less frequently among
women, and its prognostic impact is restricted to men.
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Background: Valvuloarterial impedance (Zva) is an index assessing global left
ventricular (LV) afterload that has shown to be a predictor of mortality in patients with
aortic stenosis (AS). We set out to evaluate whether improvement of Zva immediately
after balloon aortic valvuloplasty (BAV) can predict short term outcomes in high
surgical risk patients with severe AS evaluated for TAVI.B230 JACC Vol 62/18/Suppl B j October 27–NovemberMethods: 85 consecutive patients with severe AS underwent BAV. The prognostic
effectiveness of a new Zva index ratio, deﬁned as the ratio of the post-BAV Zva to the
pre-BAV Zva (post-Zva/pre-Zva), for 6-month endpoint event was evaluated in
patients not eligible for surgical valve replacement. Central systolic arterial pressure
(averaged from at least 3 measurements), mean transvalvular pressure gradient and
stroke volume index were obtained using invasive measurements.
Results: The postZva/preZva index ratio is a good predictor for 6-month endpoint
event. A cutoff value <0.85 was strongly associated with poor survival at 6 months.
Zva-derived measurements were similar between both groups with postZva/preZva
<0.85 and 0.85.Conclusions: Assessment of global LV hemodynamic load before and after BAV as
measured by the postZva/preZva index ratio may provide additional risk information
in high risk patients with severe AS evaluated for TAVR.
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Background: As the application of transcatheter aortic valve (TAV) implantation
moves towards intermediate or low risk patients, TAV durability will be a greater
concern. Current TAVs employ thin tissue leaﬂets, have limited or no stent-tip
deﬂection, and often exhibit "pinwheeled" leaﬂets due to abnormal deployment. These
factors are known to increase stress and limit the durability of surgical pericardial
valves. In this study, we present an elegant leaﬂet design of TAVs with chordal
reinforcement (Chord-TAVs) that can mitigate leaﬂet stress concentrations and
enhance overall valve durability.
Methods: Optimal designs of Chord-TAVs were obtained through computational
modeling. Chord-TAVs were fabricated from glutaraldehyde-treated thin bovine peri-
cardium sewn onto size 23woven nitinol stents. The leaﬂet strain distributions of Chord-
TAVs were measured from a static pressurization test. The Chord-TAVs were then
subjected to hydrodynamics and accelerated wear testing (AWT) per ISO-5840:2005.
Results: OptimizedChord-TAVs reduced simulated leaﬂet peak stress by 43%compared
to a chordless TAV and was comparable to simulated surgical CEP stress. The physical1, 2013 j TCT Abstracts/POSTER/Aortic Valve Disease and Treatment
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PChord-TAV strain distribution was up to 42% lower than for fabricated chordless valves.
Chord-TAVs exhibited satisfactory hydrodynamics for size 23 valves. Initial AWT
testing data indicated that strain reduction continues following cyclic loading (Fig.1). O
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SConclusions: Chord-TAVs with chordal reinforcement provided structural support
that greatly reduced leaﬂet stress and strain. Such reduction will improve valve
performance and overall valve durability.
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Background: A strong component of predicted mortality in scoring systems is
advanced age, however, outcomes data in nonagenarians (age >90 years) is lacking.
We evaluated surgical outcomes after aortic valve replacement (AVR) in nonage-
narians at our institution over an 11-year period.
Methods: Demographics, procedural details, and in-hospital outcomes were retro-
spectively analyzed on 119 patients with severe aortic stenosis (AS) who underwent
AVR or AVR+concomitant surgery between 2001 and 2012. Mean duration of
follow-up was 915832 days.
Results: The average age was 91.71.9 years (range 90-97) and mean STS score was
8.95.7. Over 98% of patients met echocardiographic criteria for severe AS (mean
gradient 45.016.1 mmHg, aortic valve area 0.660.2 cm2), had an ejection fraction
of 49.811.8%, and 47% underwent an isolated AVR. Though average length of stay
was longer than expected, rates of prolonged ventilation (16.8%), new atrial ﬁbrilla-
tion (43.7%), stroke (0.8%), and renal failure (5.9%) were acceptable. Three patients
(2.5%) required reoperation for bleeding. Overall 30 day or in-hospital mortality was
7.6%, and multivariate predictors of mortality at 1 years included prior myocardial
infarction (HR 2.79, 95% CI: 1.21-6.45, p¼0.016), obstructive lung disease (HR 3.90,
95% CI: 1.66-9.15, p¼0.025), and diabetes (HR 2.77, 95% CI: 1.08-7.07, p¼0.033).
Observed mortality at 30 days was lower than expected (observed/expected¼0.85).Table 1. Demographics and Procedural Outcomes
Concomitant surgery status, n (%)
Isolated AVR 56 (47.1%)
AVR + CABG 47 (39.5%)
AVR + MVR 10 (8.4%)
AVR + Other 6 (5.0%)
Duration of hospital stay in days
Overall 16.511.7
Isolated AVR 13.99.1
AVR + any surgery 18.713.2
Re-operation for bleeding, n (%) 3 (2.5%)
30-day or in-hospital mortality, n (%) 9 (7.6%)
Cumulative mortality at 1 year
Isolated AVR 16.1%
AVR+any surgery 25.4%
AVR- aortic valve replacement, CABG- coronary artery bypass grafting, MVR-mitral valve
replacement.Conclusions: Excellent procedural and long-term outcomes can be achieved in
nonagenarians, and age alone should not be a contraindication for valve replacementJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrin select populations. This sample cohort validates the feasibility of a primary oper-
ative strategy in elderly patients with AS and acceptable risk proﬁles.
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Background: The incidence of transcatheter heart valve (THV) device malposition is
higher during aortic valve-in-valve implantation (VinV). We aimed to evaluate for
correlates for this complication.
Methods: Aortic VinV procedures included in the Global Valve-in-Valve Registry
were investigated (459 procedures, 246 Edwards SAPIEN and 213 CoreValve).
Results: THV device malposition occurred in 50 cases (10.9%) resulting in attempted
device retreival (10.3% of CoreValve implantations) and second THV device
implantation (7.5% CoreValve vs. 4.1% Edwards SAPIEN, p¼0.052). Device
malposition was more common during CoreValve VinV procedures(16.4% vs. 6.1%,
Edwards SAPIEN, p¼0.0004). In Edwards SAPIEN VinV procedures there was no
difference in malposition rate between transfemoral and transapical procedures (4.1%
vs. 7%, p¼0.39). Device malposition was more common in procedures performed
early in the learning-curve (14.4% vs. 9% after the seventh case per center, p¼0.046),
with regurgitant bioprostheses (13.3% vs. 7.2% in bioprostheses with isolated
stenosis, p¼0.04) and with stentless and Mosaic stented valves (16.1%,14.0% vs.
9.0% in non-Mosaic stented valves, p¼0.04).
Conclusions: Device malposition is common during aortic VinV procedures and may
result implantation of a second THV device. Malposition was more common when
performed early in the learning curve, with CoreValve VinV procedures and with
regurgitant, stentless and Mosaic bioprostheses.
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Background: Low-Flow Low-Gradient (LF-LG) or "Paradoxical Aortic Stenosis" is
a rarely encountered clinical entity with limited data on clinical outcomes after
surgical (SAVR) or trans-catheter aortic valve (TAVI) replacement. We conducted
a meta-analysis of all the studies comparing all-cause mortality after aortic valve
replacement in LF-LG AS in comparison to medical therapy alone.
Methods: A thorough PubMed (time-unlimited till 06/01/2013) search revealed 5
studies comparing TAVI/SAVR outcomes in LF-LG aortic stenosis (mean gradient
<40mmHg; stroke volume index <35ml/m2). Primary clinical endpoint was all-cause
mortality at 2 year follow-up. Odds ratio (OR) and conﬁdence interval (CI) were
estimated using the random effects model.
Results: A total of 607 patients (SAVR/TAVI 263; medical therapy 344) were
included in the analysis. Baseline characteristics of these patients in valve
replacement and medical therapy arms were comparable. At 2-year follow-up,
SAVR/TAVI was associated with lower all-cause mortality (24.3% vs. 55.8%; OR
0.23; 95% CI 0.15 – 0.36). This corresponds to an absolute risk reduction of 31.5%
and a Number Needed to Treat 3.55 to save one life.acts/POSTER/Aortic Valve Disease and Treatment B231
